Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Day One Biopharmaceuticals Inc (NQ: DAWN )

24.07 -0.17 (-0.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 825,267
Open 23.93
Bid (Size) 22.71 (2)
Ask (Size) 25.00 (5)
Prev. Close 24.24
Today's Range 23.10 - 24.98
52wk Range 5.440 - 28.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
Insiders Buy Over $540M Of 2 Stocks
Although the US stocks closed slightly lower on Wednesday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
+37.78%
+37.78%
1 Month
+32.76%
+32.76%
3 Month
+217.55%
+217.55%
6 Month
+75.37%
+75.37%
1 Year
-2.75%
-2.75%

More News

Read More
Why Is Day One Biopharmaceuticals (DAWN) Stock Up 103% Today?
Via InvestorPlace
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
Via Talk Markets
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Via Benzinga
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade
Via Investor's Business Daily
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Via Benzinga
DAWN Stock Is in the Spotlight as Day One Announces Common Stock Offering
Via InvestorPlace
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
93 Biggest Movers From Yesterday
Via Benzinga
S&P 500 Slips Into Bear Market Territory As Selling Intensifies
Via Talk Markets
Day One Biopharmaceuticals Scores Triple-Digit Gain With Bullish Numbers In Brain Cancer
Via Investor's Business Daily
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Day One Biopharmaceuticals Shares Jump
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
70 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Day One Biopharma Shares Are Surging Today
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.